Johnson George E
DNA Damage Group, School of Medicine, Swansea University, Swansea, Wales, UK.
Methods Mol Biol. 2012;817:55-67. doi: 10.1007/978-1-61779-421-6_4.
Using the combination of bacterial gene mutation assay and chromosomal aberrations test in mammalian cells may not detect a small proportion of mammalian specific mutagenic agents. Therefore, at the current time a third assay should be used, except for compounds for which there is little or no exposure (DOH (2000) Department of Health Guidance for the testing of chemicals for Mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment). The hypoxanthine phosphorybosyl transferase (HPRT) gene is on the X chromosome of mammalian cells, and it is used as a model gene to investigate gene mutations in mammalian cell lines. The assay can detect a wide range of chemicals capable of causing DNA damage that leads to gene mutation. The test follows a very similar methodology to the thymidine kinase (TK) mouse lymphoma assay (MLA), and both are included in the guidelines for mammalian gene mutation tests (OECD (1997) Organisation for Economic Co-operation and Development. Ninth addendum to the OECD Guidelines for the Testing of Chemicals. In Vitro Mammalian Cell Gene Mutation Test: 476). The HPRT methodology is such that mutations which destroy the functionality of the HPRT gene and or/protein are detected by positive selection using a toxic analogue, and HPRT ( - ) mutants are seen as viable colonies. Unlike bacterial reverse mutation assays, mammalian gene mutation assays respond to a broad spectrum of mutagens, since any mutation resulting in the ablation of gene expression/function produces a HPRT ( - ) mutant. Human cells are readily used, and mechanistic studies using the HPRT test methodology with modifications, such as knock-out cell lines for DNA repair, can provide details of the mode of action (MOA) of the test compound (24).This chapter provides the methodology for carrying out the assay in different cell lines in the presence and absence of metabolism with technical information and general advice on how to carry out the test.
将细菌基因突变试验与哺乳动物细胞染色体畸变试验相结合,可能无法检测出一小部分哺乳动物特有的诱变剂。因此,目前应使用第三种试验方法,但几乎没有或没有接触风险的化合物除外(卫生部(2000年)。卫生部化学品致突变性检测指南。食品、消费品和环境中化学品致突变性委员会)。次黄嘌呤磷酸核糖转移酶(HPRT)基因位于哺乳动物细胞的X染色体上,它被用作研究哺乳动物细胞系基因突变的模型基因。该试验可以检测出多种能够导致DNA损伤进而引起基因突变的化学物质。该试验遵循的方法与胸苷激酶(TK)小鼠淋巴瘤试验(MLA)非常相似,并且这两种试验都包含在哺乳动物基因突变试验指南中(经济合作与发展组织(1997年)。经济合作与发展组织化学品测试指南第九份增编。体外哺乳动物细胞基因突变试验:476)。HPRT试验方法是通过使用有毒类似物进行阳性选择来检测破坏HPRT基因和/或蛋白质功能的突变,并且HPRT(-)突变体被视为活菌落。与细菌回复突变试验不同,哺乳动物基因突变试验对广泛的诱变剂有反应,因为任何导致基因表达/功能缺失的突变都会产生HPRT(-)突变体。人类细胞很容易使用,并且使用经过修改的HPRT试验方法进行的机制研究,例如用于DNA修复的基因敲除细胞系,可以提供受试化合物作用模式(MOA)的详细信息(24)。本章提供了在有代谢和无代谢情况下在不同细胞系中进行该试验的方法,以及有关如何进行试验的技术信息和一般建议。